OBJECTIVE: We hypothesized that interaction between PPARG2 Pro12Ala and variants in the promoter region of HNF4A are associated with type 2 diabetes-related quantitative traits in Mexican-American families of a proband with previous gestational diabetes. RESEARCH DESIGN AND METHODS: The BetaGene project genotyped PPARG2 Pro12Ala and nine HNF4A single nucleotide polymorphisms (SNPs) in 473 individuals in 89 families. Members of the proband generation had fasting glucose <126 mg/dl and were phenotyped by oral and intravenous glucose tolerance tests. RESULTS: Neither PPARG2 Pro12Ala nor any of the nine HNF4A SNPs were independently associated with type 2 diabetes-related quantitative traits. However, the interaction between PPARG2 Pro12Ala and HNF4A rs2144908 was significantly associated with both insulin sensitivity (S(I)) (Bonferroni P = 0.0006) and 2-h insulin (Bonferroni P = 0.039). Subjects with at least one PPARG2 Ala allele and homozygous for the HNF4A rs2144908 A allele had 40% higher S(I) compared with individuals with at least one G allele. S(I) did not vary by rs2144908 genotype among PPARG2 Pro/Pro. The interaction result for S(I) was replicated by the Insulin Resistance Atherosclerosis Family Study (P = 0.018) in their San Antonio sample (n = 484) where subjects with at least one PPARG2 Ala allele and homozygous for the HNF4A rs2144908 A allele had a 29% higher S(I) compared with individuals with at least one G allele. However, the interaction was not replicated in their San Luis Valley sample (n = 496; P = 0.401). CONCLUSIONS: Together, these results suggest that variation in PPARG2 and HNF4A may interact to regulate insulin sensitivity in Mexican Americans at risk for type 2 diabetes.
OBJECTIVE: We hypothesized that interaction between PPARG2Pro12Ala and variants in the promoter region of HNF4A are associated with type 2 diabetes-related quantitative traits in Mexican-American families of a proband with previous gestational diabetes. RESEARCH DESIGN AND METHODS: The BetaGene project genotyped PPARG2Pro12Ala and nine HNF4A single nucleotide polymorphisms (SNPs) in 473 individuals in 89 families. Members of the proband generation had fasting glucose <126 mg/dl and were phenotyped by oral and intravenous glucose tolerance tests. RESULTS: Neither PPARG2Pro12Ala nor any of the nine HNF4A SNPs were independently associated with type 2 diabetes-related quantitative traits. However, the interaction between PPARG2Pro12Ala and HNF4Ars2144908 was significantly associated with both insulin sensitivity (S(I)) (Bonferroni P = 0.0006) and 2-h insulin (Bonferroni P = 0.039). Subjects with at least one PPARG2Ala allele and homozygous for the HNF4Ars2144908 A allele had 40% higher S(I) compared with individuals with at least one G allele. S(I) did not vary by rs2144908 genotype among PPARG2 Pro/Pro. The interaction result for S(I) was replicated by the Insulin Resistance Atherosclerosis Family Study (P = 0.018) in their San Antonio sample (n = 484) where subjects with at least one PPARG2Ala allele and homozygous for the HNF4Ars2144908 A allele had a 29% higher S(I) compared with individuals with at least one G allele. However, the interaction was not replicated in their San Luis Valley sample (n = 496; P = 0.401). CONCLUSIONS: Together, these results suggest that variation in PPARG2 and HNF4A may interact to regulate insulin sensitivity in Mexican Americans at risk for type 2 diabetes.
Authors: H Thomas; K Jaschkowitz; M Bulman; T M Frayling; S M Mitchell; S Roosen; A Lingott-Frieg; C J Tack; S Ellard; G U Ryffel; A T Hattersley Journal: Hum Mol Genet Date: 2001-09-15 Impact factor: 6.150
Authors: J A Douglas; M R Erdos; R M Watanabe; A Braun; C L Johnston; P Oeth; K L Mohlke; T T Valle; C Ehnholm; T A Buchanan; R N Bergman; F S Collins; M Boehnke; J Tuomilehto Journal: Diabetes Date: 2001-04 Impact factor: 9.461
Authors: Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer Journal: Am J Physiol Endocrinol Metab Date: 2005-01-11 Impact factor: 4.310
Authors: S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx Journal: Nat Genet Date: 1998-11 Impact factor: 38.330
Authors: K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205
Authors: Mary Helen Black; Richard M Watanabe; Enrique Trigo; Miwa Takayanagi; Jean M Lawrence; Thomas A Buchanan; Anny H Xiang Journal: J Nutr Date: 2013-01-23 Impact factor: 4.798
Authors: Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Mary Helen Black; Jun Wu; Miwa Takayanagi; Nan Wang; Kent D Taylor; Talin Haritunians; Enrique Trigo; Jean M Lawrence; Richard M Watanabe; Thomas A Buchanan; Anny H Xiang Journal: J Clin Endocrinol Metab Date: 2015-01-13 Impact factor: 5.958
Authors: P Ungaro; R Teperino; P Mirra; M Longo; M Ciccarelli; G A Raciti; C Nigro; C Miele; P Formisano; F Beguinot Journal: Diabetologia Date: 2010-04-16 Impact factor: 10.122
Authors: Rosalind J Neuman; Jon Wasson; Gil Atzmon; Julio Wainstein; Yair Yerushalmi; Joseph Cohen; Nir Barzilai; Ilana Blech; Benjamin Glaser; M Alan Permutt Journal: PLoS One Date: 2010-03-26 Impact factor: 3.240
Authors: Xia Li; Yu-Hsiang Shu; Anny H Xiang; Enrique Trigo; Johanna Kuusisto; Jaana Hartiala; Amy J Swift; Miwa Kawakubo; Heather M Stringham; Lori L Bonnycastle; Jean M Lawrence; Markku Laakso; Hooman Allayee; Thomas A Buchanan; Richard M Watanabe Journal: Diabetes Date: 2009-09-09 Impact factor: 9.461
Authors: Rong Chen; Alex A Morgan; Joel Dudley; Tarangini Deshpande; Li Li; Keiichi Kodama; Annie P Chiang; Atul J Butte Journal: Genome Biol Date: 2008-12-05 Impact factor: 13.583